Advertisement

Featured in NEJM Journal Watch: Anti-TNF Agents Carry Low Cancer Risk — Physician’s First Watch

Medical News |
June 23, 2014

Featured in NEJM Journal Watch: Anti-TNF Agents Carry Low Cancer Risk

By the NEJM Journal Watch Editors

A JAMA study offers reassurance for patients and clinicians using anti-tumor necrosis factor drugs against inflammatory bowel disease.

Douglas K. Rex comments: "use of anti-TNF agents is not definitely associated with an increased risk for any cancer."

Reader Comments (1)

sanjay srivatsa Physician, Cardiology, fresno CA

what about new onset CHF

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement